Pfizer (PFE) Misses Q4 EPS by 6c, Raises FY21 EPS Guidance
Get Alerts PFE Hot Sheet
Price: $25.26 -3.84%
Revenue Growth %: -23.7%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: -23.7%
Financial Fact:
Cash dividends paid per common share (in dollars per share): 0.3
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.42, $0.06 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $11.7 billion versus the consensus estimate of $11.43 billion.
GUIDANCE:
Pfizer sees FY2021 EPS of $3.10-$3.20, versus the consensus of $3.19. Pfizer sees FY2021 revenue of $59.4-61.4 billion, versus the consensus of $56.72 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Snap shares surge 26% on earnings beat, optimistic outlook
- Primis Financial (FRST) Misses Q1 EPS by 8c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!